Benign Positional Vertigo. Benign paroxysmal Positional vertigo
Conditions
Interventions
Intervention 1: Intervention group: The first group was treated with cinnarizine 25 mg and placebo 3 times a day. Intervention 2: Intervention group: The second group received 1 week treatment with be
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age more than 18 years old Age less than 60 years old patients referred with Benign Positional Vertigo (BPV) Did not use drug before reference
Exclusion criteria
Exclusion criteria: Meniere syndrome Vertigo caused by untreated primary organ disease Pregnancy Patients use Benzodiazepines, CNS suppressant, Barbiturates History of internal and middle ear surgery Migraine headaches Headache at the time of study A history of mental or neurological illness Gastric ulcer and digestive problems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of positional vertigo. Timepoint: At first, 3rd days and 1 week later. Method of measurement: Visual Analog Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Significance improvement. Timepoint: 3rd days and 1 week later after treatment. Method of measurement: Mean Vertigo Score (MVS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Peyman Asadi
Rasht University of Medical Sciences
Outcome results
None listed